Business Description
Mirum Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US6047491013
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.99 | |||||
Equity-to-Asset | 0.36 | |||||
Debt-to-Equity | 1.31 | |||||
Debt-to-EBITDA | -2.41 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 0.59 | |||||
Beneish M-Score | -2.87 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 6.2 | |||||
3-Year EPS without NRI Growth Rate | 9.3 | |||||
3-Year FCF Growth Rate | 14.3 | |||||
3-Year Book Growth Rate | -2.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 41.52 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 63.25 | |||||
9-Day RSI | 59.79 | |||||
14-Day RSI | 54.8 | |||||
6-1 Month Momentum % | -13.67 | |||||
12-1 Month Momentum % | 1.69 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.68 | |||||
Quick Ratio | 3.47 | |||||
Cash Ratio | 2.86 | |||||
Days Inventory | 99.08 | |||||
Days Sales Outstanding | 73.91 | |||||
Days Payable | 62.96 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.2 | |||||
Shareholder Yield % | -17.14 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 73.26 | |||||
Operating Margin % | -48.43 | |||||
Net Margin % | -70.79 | |||||
FCF Margin % | -18.85 | |||||
ROE % | -81.56 | |||||
ROA % | -29.08 | |||||
ROIC % | -49.81 | |||||
ROC (Joel Greenblatt) % | -2240.2 | |||||
ROCE % | -30.34 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 4.9 | |||||
PB Ratio | 5.03 | |||||
EV-to-EBIT | -8.16 | |||||
EV-to-EBITDA | -8.8 | |||||
EV-to-Revenue | 6.45 | |||||
EV-to-Forward-Revenue | 3.8 | |||||
EV-to-FCF | -28.58 | |||||
Earnings Yield (Greenblatt) % | -12.25 | |||||
FCF Yield % | -7.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Mirum Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 206.793 | ||
EPS (TTM) (€) | -3.473 | ||
Beta | -0.16 | ||
Volatility % | 39.05 | ||
14-Day RSI | 54.8 | ||
14-Day ATR (€) | 0.442032 | ||
20-Day SMA (€) | 22.95 | ||
12-1 Month Momentum % | 1.69 | ||
52-Week Range (€) | 21.8 - 31.6 | ||
Shares Outstanding (Mil) | 47.12 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mirum Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mirum Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Mirum Pharmaceuticals Inc Frequently Asked Questions
What is Mirum Pharmaceuticals Inc(FRA:08D)'s stock price today?
When is next earnings date of Mirum Pharmaceuticals Inc(FRA:08D)?
Does Mirum Pharmaceuticals Inc(FRA:08D) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |